Has COVID-19 Led to More Advanced Cancers?

March 29, 2021

Months of lockdowns throughout 2020 brought mass cancer screening programs to a halt in the United States. Early in the COVID-19 pandemic, the American Cancer Society recommended that "no one should go to a health care facility for routine cancer screening."

For example, from March to June 2020 at Massachusetts General Hospital in Boston, cancer screening fell by 60%-82% for five common screening tests: low-dose CT, Pap smear, colonoscopy, prostate-specific antigen testing, and mammography.

Oncologists and pathologists have wondered whether the pause in screening will ultimately leave patients with asymptomatic cancers or precursor lesions worse off.

Tell us whether restrictions on cancer screening over the last year have affected the clinical presentation of your patients.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.